Actisomide

N/A

Report date: 2022/03/22 11:18:38

NME

Base Information

Drug NameActisomide

Drug Alias NameSC-36602

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium channel alpha subunit blockers

TargetsSodium channel alpha subunit

Therapy Area/IndicationsArrhythmias, Cardiac

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsArrhythmias, Cardiac

ATC CodeN/A